200 likes | 824 Views
Topics. DissolutionpHPolymorphismParticleIonic formPharmceutical examplesGriseofulvin, nitrofurantoin, erythromycin. Dissolution rate. pH partition hypothesisDeveloped for drugs in solutionBut many drugs are given orally as solidsSolubilityDoes solubility always predict dissolution rate?T
E N D
1. Preformulation considerations in biopharmaceutics Gregory Poon
PHM224Y
October 11, 2002
Study version
2. Topics Dissolution
pH
Polymorphism
Particle
Ionic form
Pharmceutical examples
Griseofulvin, nitrofurantoin, erythromycin
3. Dissolution rate pH partition hypothesis
Developed for drugs in solution
But many drugs are given orally as solids
Solubility
Does solubility always predict dissolution rate?
Thermodynamics vs. kinetics
pH dependence of solubility
Acid/base/neither
4. Acid-base theory Based on solubility in aqueous solution
Not very vigorous, often problematic
“Acid is charged when deprotonated”
“Base is charged when protonated”
5. pKa: the classic trap pKa alone does not determine acid or base
Indicates only how acidic or basic
Must know chemistry!
All of the following have pKa ~ 9, but which are acids and which are bases?
6. Solubility considerations Polymorphism
Polymorphs have different physical properties
Convert to most stable form at given T, p
But at what rate?
Possible limit on shelf life
Particle size
Surface area vs. volume
Why do oil droplets coalesce? (To minimize total SA)
Decreasing particles size improves dissolution
Important for hydrophobic drugs
7. Salt form & solubility Not all salts are equally soluble
Example: calcium supplements
Ca salts not very soluble generally
Soap scum (divalent salts of fatty acid)
Solubility increases with falling pH
Removing scale/stain (Ca(OH)2, etc.) with vinegar
Ca2CO3 not very soluble
Calcium citrate is more soluble at all pH
Improved bioavailability
Even in achlorhydric patients
8. Example: griseofulvin Antifungal
Very hydrophobic
Need to take with fatty meals
Decreasing particle size reduces dose requirements
“Regular” = 1 g/day
Microsize = 500 mg/day (Fulvicin U/F®)
Ultramicrosize = 250 mg/day (Fulvicin P/G®)
9. Example: nitrofurantoin pKa 7.2
Antibacterial
Uncomplicated UTI
Where does absorption occur after oral administration?
Stomach
Small intestine
10. Nitrofurantoin crystals Anhydrous nitrofurantoin
Microcrystal (<10 µm)
Macrocrystal (74-177 µm)
Which dissolves more quickly?
Microcrystals: nausea, vomiting
Nitrofurantoin monohydrate
Pseudopolymorph
11. Oral dosage forms Oral suspension (5 mg/mL)
Capsule of macrocrystal (Macrodantin®, generics)
Adult: 50-100 mg qid (treatment)
Capsule of macrocrystal/monohydrate (MacroBID®)
100 mg bid
12. MacroBID “Tablets within a capsule”
Hard capsule containstwo pellets
75 mg as macrocrystal
25 mg as monohydrate
Macrocrystal is contained in delayed-release gel matrix
Prevents dose dumping
13. Example: erythromycin Erythromycin base (pKa ~ 8)
Hydroylzable at acidic pH
Supposed to take on emptystomach to hurry emptying
(Also makes you puke on empty stomach)
Strategies
Encapsulate in enteric coating (Eryc®, PCE®)
14. Erythromycin salts Organic salts are much less soluble
Base: 2 mg/mL
Estolate: 0.024 mg/mL
Stearate: <0.01 mg/mL
Solution chemistry cannot occur if reactants are not dissolved